Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab

from JAMA Otolaryngology–Head & Neck Surgery Author Interviews

Interview with Jennifer M. Johnson, MD, PhD and Adam J. Luginbuhl, MD authors of A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. Hosted by Paul C. Bryson, MD MBA. Related Content: Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab Emerging Role of Pathologic Response in Head and Neck Squamous Cell Carcinoma Immunotherapy

Episode metadata supplied by the publisher feed · Published Jul 31, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab

0:00 17:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Otolaryngology–Head & Neck Surgery Author Interviews?

This episode is 17 minutes long.

When was this JAMA Otolaryngology–Head & Neck Surgery Author Interviews episode published?

This episode was published on July 31, 2025.

Can I download this JAMA Otolaryngology–Head & Neck Surgery Author Interviews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!